TSH: How to Interpret Your Result

What TSH Actually Measures

TSH is a pituitary hormone that tells the thyroid gland how hard to work. When thyroid hormone levels fall, the pituitary releases more TSH to stimulate production. When thyroid hormone is abundant, TSH drops. This feedback loop makes TSH an extraordinarily sensitive marker of thyroid status, often shifting days to weeks before free T4 moves out of range.

The Hypothalamic-Pituitary-Thyroid Axis

The hypothalamus releases thyrotropin-releasing hormone (TRH), which signals the pituitary to secrete TSH. TSH then binds receptors on the thyroid and drives synthesis of thyroxine (T4) and triiodothyronine (T3). Free T4 and free T3 feed back negatively to both the hypothalamus and pituitary, completing the loop. Because TSH sits at the top of this cascade, a small change in circulating thyroid hormone produces a proportionally large change in TSH, which is why the test carries such diagnostic weight [1].

Why TSH Is the First Test Ordered

The American Association of Clinical Endocrinology (AACE) recommends TSH as the first-line screening test for thyroid dysfunction in symptomatic patients [2]. Free T4 and free T3 are ordered as second-step tests when TSH is abnormal. Ordering free T4 alone without TSH misses subclinical disease in a large proportion of patients because TSH responds earlier and more sharply.

A 2019 analysis in the Journal of Clinical Endocrinology and Metabolism confirmed that TSH alone detects 98 to 99% of primary thyroid disorders when the assay generation is third-generation or higher (functional sensitivity <0.02 mIU/L) [3].

Normal TSH Range: What the Numbers Mean

The "normal" reference interval printed on your lab report is 0.45 to 4.5 mIU/L for most major U.S. Laboratories, but context changes how that number should be read. Age, sex, pregnancy, and treatment status all shift what counts as a reassuring result.

Population Reference Intervals

The National Academy of Clinical Biochemistry established reference intervals using a carefully selected population of thyroid-antibody-negative, iodine-replete adults with no family history of thyroid disease. That analysis set the 95th percentile upper limit near 4.12 mIU/L [4]. Many labs still report 4.5 mIU/L as the upper bound because it accommodates broader demographic variation.

TSH rises modestly with age. Adults older than 70 years commonly have TSH values near 5 to 6 mIU/L that are physiologically normal for their age cohort. A 2010 study in the Archives of Internal Medicine (N=13,344) found that the 97.5th percentile for TSH in adults aged 70 to 79 was 7.49 mIU/L, compared with 3.56 mIU/L in those aged 20 to 29 [5].

TSH During Pregnancy

Pregnancy suppresses TSH. The American Thyroid Association (ATA) 2017 guidelines recommend trimester-specific targets [6]:

• First trimester: 0.1 to 2.5 mIU/L
• Second trimester: 0.2 to 3.0 mIU/L
• Third trimester: 0.3 to 3.0 mIU/L

Using the standard adult upper limit of 4.5 mIU/L during the first trimester would miss a clinically meaningful number of pregnant women with hypothyroidism, which carries risks for fetal neurodevelopment.

TSH on Levothyroxine Therapy

Patients taking levothyroxine for hypothyroidism are generally targeted to a TSH of 0.5 to 2.5 mIU/L, though the AACE and ATA acknowledge that some individuals feel best at the lower end of that range [2]. A TSH above 4.5 mIU/L while on therapy usually signals an inadequate dose. A suppressed TSH (<0.1 mIU/L) on replacement therapy raises concern for overtreatment and associated risks including atrial fibrillation and bone loss [7].

What a High TSH Means

A TSH above the laboratory's upper reference limit, typically 4.5 mIU/L, indicates that the pituitary is working overtime to stimulate a thyroid gland that is not producing enough hormone. This pattern is called hypothyroidism at the overt level and subclinical hypothyroidism when free T4 remains normal.

Subclinical vs. Overt Hypothyroidism

Subclinical hypothyroidism is defined as a TSH of 4.5 to 10 mIU/L with a normal free T4. It affects roughly 4 to 8% of the general U.S. Population and up to 15 to 18% of women older than 60 [8]. Overt hypothyroidism carries TSH above 10 mIU/L alongside a low free T4, and symptoms are typically more pronounced: fatigue, cold intolerance, constipation, bradycardia, and weight gain.

Common Causes of Elevated TSH

The most frequent cause of high TSH in iodine-sufficient countries is Hashimoto thyroiditis (autoimmune thyroiditis), which accounts for roughly 90% of hypothyroidism cases in the United States [9]. Thyroid peroxidase (TPO) antibodies are elevated in most affected individuals. Other causes include:

• Prior radioactive iodine therapy or thyroid surgery
• Central iodine deficiency (rare in the U.S.)
• Certain drugs: amiodarone, lithium, interferons, checkpoint inhibitors
• Pituitary TSH-secreting adenoma (rare; causes high TSH with high free T4)

When to Treat a High TSH

The AACE and ATA recommend initiating levothyroxine when TSH exceeds 10 mIU/L, or at lower TSH values (4.5 to 10 mIU/L) when the patient has symptoms, positive TPO antibodies, or is pregnant [2]. A landmark 2017 randomized trial published in the New England Journal of Medicine (the TRUST trial, N=737) found that levothyroxine treatment for subclinical hypothyroidism in adults older than 65 did not improve hypothyroid symptoms or quality of life compared to placebo, adding nuance to blanket treatment decisions in elderly patients [10].

What a Low TSH Means

A TSH below 0.45 mIU/L signals that the pituitary is being suppressed by excess thyroid hormone. The source of that excess may be the thyroid itself, exogenous thyroid hormone, or, rarely, pituitary pathology.

Subclinical vs. Overt Hyperthyroidism

Subclinical hyperthyroidism is defined as a suppressed TSH (<0.45 mIU/L) with normal free T4 and free T3. Overt hyperthyroidism shows a suppressed TSH alongside elevated free T4 or free T3. Symptoms of overt disease include palpitations, heat intolerance, unintentional weight loss, anxiety, tremor, and diarrhea.

Common Causes of Low TSH

Graves disease accounts for approximately 60 to 80% of hyperthyroidism cases in iodine-sufficient populations [11]. It is an autoimmune condition driven by TSH-receptor antibodies (TRAb) that mimic TSH and constitutively stimulate the gland. Other causes include:

• Toxic multinodular goiter
• Toxic adenoma
• Subacute (de Quervain) thyroiditis, which is often self-limiting
• Excessive levothyroxine or liothyronine dosing
• Postpartum thyroiditis (transient)

A TSH of 0.1 to 0.45 mIU/L with normal free hormones (mildly suppressed) is often watched rather than treated immediately, particularly in older adults where new-onset Graves disease is less common and toxic nodules are more likely.

Cardiac and Bone Risks of Low TSH

A suppressed TSH, even without overt free hormone elevation, carries real physiological consequences. A meta-analysis in JAMA Internal Medicine found that subclinical hyperthyroidism was associated with a 68% increased risk of atrial fibrillation (HR 1.68; 95% CI 1.16 to 2.43) compared to euthyroid controls [12]. Bone mineral density also declines: postmenopausal women with endogenous subclinical hyperthyroidism lose cortical bone at a measurably faster rate than those with normal TSH [13].

How to Lower a High TSH

Lowering an elevated TSH means correcting the underlying thyroid insufficiency, usually with levothyroxine (synthetic T4).

Levothyroxine Dosing Principles

The standard starting dose of levothyroxine for otherwise healthy adults with overt hypothyroidism is 1.6 mcg/kg/day, though older or cardiac-compromised patients start lower (25 to 50 mcg/day) to avoid precipitating arrhythmia [2]. Dose adjustments are made in 12.5 to 25 mcg increments. TSH should be rechecked 6 to 8 weeks after any change; it takes that long for the pituitary to re-equilibrate.

Brand consistency matters. The FDA classifies levothyroxine as a narrow therapeutic index drug, meaning small formulation differences between brands (Synthroid, Levoxyl, Tirosint) can shift TSH measurably. Generic-to-brand or brand-to-brand switches should trigger a TSH recheck at 6 to 8 weeks [14].

Dietary and Drug Interactions That Affect Absorption

Several factors reduce levothyroxine absorption and can cause TSH to remain elevated despite adequate prescribed doses:

• Calcium carbonate and ferrous sulfate: take levothyroxine at least 4 hours apart
• Proton pump inhibitors: reduce gastric acid and impair T4 absorption
• High-fiber diets: may bind levothyroxine in the gut
• Coffee: delays absorption; take levothyroxine 30 to 60 minutes before coffee

Tirosint (levothyroxine gel capsule) may avoid some absorption issues because it contains fewer excipients [15].

Non-Pharmacological Considerations

Adequate selenium and iodine intake support thyroid hormone synthesis. Selenium supplementation (200 mcg/day) reduced TPO antibody titers by 49% in a 2002 randomized trial (N=70) published in the Journal of Clinical Endocrinology and Metabolism [16]. It does not, however, restore normal TSH once overt Hashimoto hypothyroidism is established. Iodine excess can paradoxically worsen autoimmune thyroid disease via the Wolff-Chaikoff effect, so mega-dose iodine supplements are not recommended.

How to Raise a Low TSH

A persistently suppressed TSH requires treatment directed at the source of thyroid hormone excess.

Treating Graves Disease

The three options for Graves disease are anti-thyroid drugs (ATDs), radioactive iodine (RAI) ablation, and thyroidectomy. Methimazole is the preferred ATD in the U.S. At initial doses of 10 to 30 mg/day, titrated to normalize free T4 and allow TSH to recover [11]. The ATA 2016 guidelines note that methimazole is favored over propylthiouracil (PTU) except during the first trimester of pregnancy or in thyroid storm [11].

TSH may remain suppressed for weeks to months even after free T4 normalizes because the pituitary gland needs time to recover its sensitivity. A still-low TSH with a normal free T4 at 8 to 12 weeks of ATD therapy is not necessarily a sign of undertreated hyperthyroidism; it may simply reflect pituitary lag.

Adjusting Overtreatment With Levothyroxine

If suppressed TSH results from excessive levothyroxine dosing, the fix is straightforward: reduce the dose by 12.5 to 25 mcg and recheck TSH in 6 to 8 weeks. Patients who feel best with a slightly low TSH should be counseled on the atrial fibrillation and bone-density risks documented above before continuing on a suppressive dose long-term.

The HealthRX clinical team uses a three-tier decision framework for low TSH on levothyroxine:

1. TSH 0.1 to 0.45 mIU/L with normal free T4/T3 and no symptoms: reduce dose by 12.5 mcg, recheck in 6 to 8 weeks.
2. TSH <0.1 mIU/L with normal free T4/T3: reduce dose by 25 mcg, order bone density if postmenopausal, recheck in 6 to 8 weeks.
3. TSH <0.01 mIU/L or elevated free T4/T3: stop or drastically reduce dose, same-week cardiology or endocrinology referral if palpitations present.

Factors That Affect TSH Results Beyond Thyroid Disease

Not every abnormal TSH reflects a thyroid problem. Several non-thyroidal conditions and medications shift TSH independently.

Medications That Alter TSH

Dopamine and glucocorticoids in pharmacologic doses suppress TSH secretion centrally. Amiodarone, which contains 37% iodine by weight, can cause either hypothyroidism or hyperthyroidism and makes TSH interpretation especially complex [17]. Biotin supplementation at doses above 5 mg/day interferes with immunoassay-based TSH measurements and can produce falsely low TSH results. The FDA issued a safety communication on this in 2017 [18]. Patients should stop biotin for at least 48 hours before thyroid blood draws.

Non-Thyroidal Illness and Euthyroid Sick Syndrome

Severe non-thyroidal illness (sepsis, major surgery, advanced malignancy) suppresses TSH as part of a global metabolic downshift. This pattern, called euthyroid sick syndrome or non-thyroidal illness syndrome (NTIS), produces low TSH and low T3 without true pituitary or thyroid pathology. Treating NTIS with levothyroxine does not improve outcomes and may worsen them; expert consensus recommends against routine thyroid hormone replacement in critically ill patients with NTIS [19].

Diurnal and Seasonal Variation

TSH follows a diurnal rhythm, peaking between midnight and 4 a.m. And reaching its nadir around 4 p.m. Draws taken at different times of day can differ by up to 50%. For patients on thyroid replacement therapy, consistent morning fasting draws before the day's levothyroxine dose give the most reproducible results and avoid the transient TSH suppression that occurs 2 to 4 hours after ingestion [20].

When to Order Additional Thyroid Tests

TSH alone is not always sufficient. The following scenarios call for adding free T4, free T3, or thyroid antibodies.

Free T4

Order free T4 whenever TSH is outside the reference range. A low free T4 with high TSH confirms overt primary hypothyroidism. A low free T4 with a low or normal TSH suggests central (secondary) hypothyroidism from pituitary disease, which is rare but important not to miss.

Free T3

Free T3 is most useful in suspected hyperthyroidism when TSH is suppressed but free T4 is normal. This pattern characterizes T3-toxicosis, which accounts for roughly 5% of hyperthyroidism cases and would be missed by a free T4 alone [11].

Thyroid Antibodies

TPO antibodies and thyroglobulin antibodies confirm autoimmune etiology in hypothyroidism. TRAb (TSH-receptor antibodies) confirm Graves disease and guide decisions about ATD discontinuation; a negative TRAb after 12 to 18 months of methimazole is associated with a 50 to 60% chance of sustained remission [11].

Thyroid Ultrasound

Ultrasound is not a first-line test for interpreting TSH but becomes relevant when TSH is suppressed and a nodule or goiter is palpated, or when Graves disease needs to be distinguished from toxic multinodular goiter by gland architecture.

Putting It All Together: A Clinical Summary

Reading a TSH result requires knowing the patient's age, pregnancy status, symptoms, current medications, and prior thyroid history. A TSH of 5.2 mIU/L means something different in a 28-year-old woman with fatigue and a rising TPO antibody titer than it does in a healthy 75-year-old male with no symptoms.

The Endocrine Society's 2012 clinical practice guideline on thyroid function testing states: "TSH measurement is the single best screening test of thyroid function in ambulatory patients, providing that the clinician is aware of the conditions in which TSH may be misleading" [21].

That caveat covers the scenarios detailed above: pregnancy, pituitary disease, non-thyroidal illness, biotin supplementation, and dopaminergic drugs. Outside those contexts, a TSH within 0.45 to 4.5 mIU/L, drawn fasting in the morning, is strong evidence of normal thyroid function.

For patients on levothyroxine, the treatment target TSH is 0.5 to 2.5 mIU/L; recheck TSH 6 to 8 weeks after any dose adjustment, after a formulation switch, or after starting or stopping any of the interfering medications listed above.